Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong · Delayed Price · Currency is HKD 5.21
-0.02 (-0.38%)
Jan 21, 2026, 2:48 PM HKT
HKG:9989 Revenue
Shenzhen Hepalink Pharmaceutical Group had revenue of 1.38B CNY in the quarter ending September 30, 2025, with 11.82% growth. This brings the company's revenue in the last twelve months to 5.38B, down -0.96% year-over-year. In the year 2024, Shenzhen Hepalink Pharmaceutical Group had annual revenue of 5.26B, down -3.17%.
Revenue (ttm)
5.38B CNY
Revenue Growth
-0.96%
P/S Ratio
3.11
Revenue / Employee
2.80M CNY
Employees
1,926
Market Cap
18.33B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.26B | -172.06M | -3.17% |
| Dec 31, 2023 | 5.43B | -1.73B | -24.14% |
| Jan 1, 2023 | 7.16B | 794.23M | 12.48% |
| Jan 1, 2022 | 6.37B | 1.03B | 19.38% |
| Dec 31, 2020 | 5.33B | 707.42M | 15.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Pharmaceutical Group | 285.94B |
| The United Laboratories International Holdings | 15.45B |
| Grand Pharmaceutical Group | 11.70B |
| Luye Pharma Group | 6.76B |
| Sunshine Lake Pharma | 3.96B |
| Consun Pharmaceutical Group | 3.58B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| CanSino Biologics | 1.06B |